Skip to main content
. 2024 May 10;6(1):vdae073. doi: 10.1093/noajnl/vdae073

Figure 2.

Figure 2.

Overall survival (OS) for all 58 patients from time of pulsed reduced-dose rate, stratifying for grade at time of progression; those that remained grade 2, transformed to grade 3, or transformed to grade 4.